Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Biomarker discovery Driving technologies" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Biomarker discovery Driving technologies for you to read. Along with our medical data and news we also list Biomarker discovery Driving technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biomarker discovery Driving technologies Companies for you to search.
Stemina Biomarker Discovery Inc. today announced the launch of the largest clinical study of the metabolism of children with autism spectrum disorder (ASD) ever conducted.Read more about Stemina Biomarker Discovery Launches Largest Ever Clinical Study
Oxford BioDynamics is expanding its biomarker discovery programme for the development of companion diagnostic tests for Amyotrophic Lateral Sclerosis (ALS), using its EpiSwitch technology
Biomarkers of Cancer Larry H. Bernstein, MD, FCAP, Curator LPBI Biomarker Discovery Gets a Fix on Cancer GEN Feb 1, 2016 (Vol. 36, No. 3) http://www.genengnews.com/gen-articles/biomarker-discovery-gets-a-fix-on-cancer/5674/ Just Because Cancer Is a Moving Target—Emerging Here, Eluding Treatment There—Doesn’t Mean It Can’t Be Tracked Kathy Liszewsky http://www.genengnews.com/Med...
Researchers may have found a biomarker for episodic migraine in the blood, a discovery that could have implications for the diagnosis and treatment of the condition.
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers from Queen Mary University of London have found. The discovery could lead to a non-invasive, inexpensive test to screen people at high risk of developing the disease.Read more
Robert Little, the Chief Business Officer of Denovo Biomarkers reveals to Fintan Walton the use of its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples.
(American Thoracic Society) Researchers in Taiwan have identified a biomarker that detects the most common lung cancer in its earliest stage. The discovery could one day change how long lung cancer patients live.
Scientists part-funded by Breast Cancer Now, Human Genetics Foundation (HuGeF), and the Cancer Council Victoria (Melbourne, Australia) have identified a new biomarker in the blood that could help identify more women at an increased risk of breast cancer...
Researchers at the Johns Hopkins University School of Medicine may have found a new blood biomarker for episodic migraines, according to recent research. Read more about Potential New Biomarker for MigrainesComments
Epistem plc, the UK biotechnology and personalised medicine company today announced a collaboration with sanofi-aventis U.S. Inc. relating to the use of Epistem's proprietary biomarker gene expression profiling and immunohistochemistry technologies. Under the terms of the agreement sanofi-aventis has entered into a 3 year collaboration with Epistem to provide discovery through to clinical biomarke...
Biomarkers, such as those sought for Alzheimer’s disease, are benchmarks in the body that can be reliably measured to indicate the presence or absence of a disease, or the likelihood of later developing a disease. For example, blood glucose levels are a biomarker for diabetes, and blood cholesterol levels are a biomarker for heart disease. The strongest biomarker candidates for
Researchers have found a biomarker that appears active in the growth and spread of triple-negative breast cancer. Known as interleukin-13 receptor alpha 2 (IL13Ralpha2), the biomarker may help doctors identify patients at high risk of disease spread and potentially provide a target for treatment. These findings were reported in Breast Cancer Research. The majority of […] The post Biomarker M...
SOURCE September 15, 2015 Genfit has boomed in stock market value by 15% since it announced its novel biomarker system for liver disease Non-alcoholic steatohepatitis (NASH). Phase III trials for its drug Elafibranor will incorporate this biomarker system, negating the need for liver biopsies in diagnosis and monitoring of NASH. […]
A new study identified the molecule known as N1,N12-diacetylspermine as a potential biomarker for early-stage non–small-cell lung cancer.
(Pancreatic Cancer Research Fund) A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, UK researchers have found. The discovery could lead to a non-invasive, inexpensive test to screen people at high risk of developing the disease.
(Queensland University of Technology) Warning labels on medications about the dangers of driving are not enough to stop people getting behind the wheel with most driving while affected by drugs, according to (QUT) Queensland University of Technology road safety researcher Dr Tanya Smyth.
23 October 2015: BBC Radio Kent covered a piece about new roadside tests for drug driving. RPS spokesperson Katie Perkins was interviewed by the programme and said: “If you’re worried that your medicine could affect your driving, you should speak to your pharmacist. And even if it’s not one of the [medicines] that’s affected by this new law, any medicine at all that’s affecting your dri...
* Announces the development of a new reliable and non-invasive diagnostic method, based on the measurement of a novel type of blood biomarker: small non-coding RNA, or miRNA
San Diego, CA, November 08, 2015 --(PR.com)-- R&D spending in biomarkers coupled with increased healthcare expenditure and growing utility of biomarkers for diagnostics is driving the biomarkers market worldwide. Growing at a CAGR of 13.58% from 2015 to 2020, the global biomarkers market is estimated to reach $45.55 billion by 2020. Aiding the growth are new developments in biomarker research...
Biomarkers that predict efficacy and safety for a given drug therapy become increasingly important for treatment strategy and drug evaluation in personalized medicine. Methodology for appropriately identifying and validating such biomarkers is critically needed, although it is very challenging to develop, especially in trials of terminal diseases with survival endpoints. The marker‐by‐treatmen...
Collaboration to Utilize KineMed’s Proprietary Kinetic Biomarker Platform Technology to Discover and Develop Novel Biomarkers in Multiple Therapy Areas KineMed Inc. today announced that it has entered into a strategic collaboration with Pfizer Inc. (NYSE:PFE) to discover and develop novel proprietary biomarkers in various fields of unmet medical need...
(Columbia University's Mailman School of Public Health) While 81 percent of the 29.5 million older U.S. adults continue to hold a license and get behind the wheel, age-related declines in cognition and physical function make driving more difficult, and many seniors eventually stop driving altogether. Researchers examined the health of older adults after they stopped driving and found that driving ...
The severity of drunk driving within a state is not the most important predictor of whether states adopt new laws to restrict drunk driving -- nor is the political makeup of the state government. Instead, a study shows, the two strongest predictors of states adopting their first drunk driving laws were having a large population of young people and a neighboring state with similar driving laws.